« Back to Focusing on the Journey
- Message from the Director
- Chair, Board of Governors Message
- Board of Governors
- Leadership
- Sylvester Locations
- Sylvester by the Numbers
-
- Sylvester Investigator’s Hodgkin Lymphoma Protocol Could Change Care for Relapsed, Refractory Patients
- Sylvester Physician-Scientist Receives Doris Duke Charitable Foundation Grant
- Junior Researcher Lands Competitive Grants for Pancreatic Cancer Focus
- Sylvester Researcher Chosen for Bristol Myers Squibb Foundation’s Career Development Program
- Sylvester Part of Groundbreaking NIH Trial Proving Anal Cancer Can Be Prevented
- The Childhood Cancer Project Focuses On Cures
-
- Health Economist Heads Commission to Examine Global Cancer Care Inequities
- Dr. Chad Ritch Appointed Member of American College of Surgeons Commission on Cancer
- Sylvester Launches New Program To Prevent Breast Cancer In Those At High Risk
- VA Honors Investigator For Gastric Cancer Research
- Keeping Cancer In Its Place: Key Protein Identified
- Phase 1 Program
-
- WHO Taps Sylvester in Global Fight Against Cervical Cancer
- Groundbreaking Research
- Community Outreach
- Orthopaedic Surgeon, Researcher Dr. Francis Hornicek Returns To Miami
- Sarcoma Specialist’s Return Elevates Sylvester Orthopaedic Oncology
- Dr. Marijo Bilusic Joins Sylvester as Genitourinary Site Leader
- Cancer Control Leader Joins Sylvester
- Educational Pathways Fuel Robust Cancer Research Pipeline
- Target: Multiple Myeloma Cure
- Educator
-
- Committed to Survivors’ Quality of Life
- Multidisciplinary Clinic
- Tackling Hispanic Cancer Disparities
- Training The Next Generation of Researchers in Disparities, Equity
- Researcher Drives Efforts To Educate Youth About E-Cigs, Hookahs
- Sylvester Studies Cancer Patient Advocacy Group’s Impact on Outcomes
- Clinic Addresses Sexual Dysfunction In Cancer Survivors
-
Fueled by a two-year, $460,000 grant by the Leukemia and Lymphoma Society, the world’s largest advocacy organization for patients with blood cancers, Sylvester is conducting one of the first studies of its kind to evaluate the society’s impact on patient outcomes.
An accomplished research team led by Frank J. Penedo, Ph.D., is spearheading the research that includes other NCI-designated cancer centers also dedicated to assessing the society’s impact on patients’ access to care, quality of life, and financial burden. They also will assess if the effects of its services and programs vary by such things as patient age, race/ethnicity, education, and insurance.